This activity is part of PrimaryCareNOW: Live on March 18-19, 2021.

Credits

0 Credits - Not for CME/CE Credit

Release Date: 3/19/2021

Expiration Date: 3/19/2021

Topics

Diabetes, Cardiovascular Risk in Diabetes

Faculty

OVERVIEW

The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

Faculty

 

John E. Anderson, MD

Internal Medicine and Diabetes 
The Frist Clinic
Nashville, TN

Fine Print

Computer System Requirements  

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.